XML 58 R47.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue Recognition - Additional Information (Detail)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
HEPLISAV-B    
Valuation And Qualifying Accounts Disclosure [Line Items]    
Concentration risk, percentage 75.00% 68.00%
HEPLISAV-B | Revenue | Credit Concentration Risk    
Valuation And Qualifying Accounts Disclosure [Line Items]    
Concentration risk, customer three largest Customers  
CpG 1018    
Valuation And Qualifying Accounts Disclosure [Line Items]    
Concentration risk, percentage 87.00%  
CpG 1018 | Revenue | Credit Concentration Risk    
Valuation And Qualifying Accounts Disclosure [Line Items]    
Concentration risk, customer one customer